Cart
sales@molnova.com
Lapisteride
CAS No. 142139-60-4
Lapisteride( —— )
Catalog No. M34309 CAS No. 142139-60-4
Lapisteride (CS-891) a steroidal 5α-reductase inhibitor is used to treat benign prostatic hyperplasia (BPH) and androgenetic alopecia and may be effective in preventing or treating AGA .
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 122 | Get Quote |
|
| 5MG | 171 | Get Quote |
|
| 10MG | 247 | Get Quote |
|
| 25MG | 466 | Get Quote |
|
| 50MG | 626 | Get Quote |
|
| 100MG | 871 | Get Quote |
|
| 500MG | 1737 | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameLapisteride
-
NoteResearch use only, not for human use.
-
Brief DescriptionLapisteride (CS-891) a steroidal 5α-reductase inhibitor is used to treat benign prostatic hyperplasia (BPH) and androgenetic alopecia and may be effective in preventing or treating AGA .
-
DescriptionLapisteride (CS 891) is an orally active 5α-reductase inhibitor. Lapisteride can be used in cancer research.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number142139-60-4
-
Formula Weight464.64
-
Molecular FormulaC29H40N2O3
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESC[C@@]12[C@]([C@]3([C@@]([C@]4(C)[C@@](CC3)(NC(=O)C=C4)[H])(CC1)[H])[H])(CC[C@@H]2C(NC(C)(C)C5=CC=C(OC)C=C5)=O)[H]
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Yada S, et al. Solid phase transition of CS-891 enantiotropes during grinding. Int J Pharm. 2003 Apr 14;255(1-2):69-79. ?
molnova catalog
related products
-
AC-261066
AC-261066 is a retinoic acid beta2 (beta2) receptor agonist (pEC50: 8.0).
-
Bis(2-ethylhexyl)hex...
Bis(2-ethylhexyl)hexanedioate (NSC 56775) is a diester produced by the formal condensation of the carboxyl group of adipic acid with 2-ethylhexan-1-ol, and is used as a plasticizer in the preparation of various polymers.
-
Fradiomycin
Fradiomycin or neomycin, an aminoglycoside antibiotic, is first isolated in 1949 from the gram-positive bacillus Streptomyces fradiae.
